Peter Schueler
YOU?
Author Swipe
View article: Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials.
Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials. Open
The placebo response is a highly complex psychosocial-biological phenomenon that has challenged drug development for decades, particularly in neurological and psychiatric disease. While decades of research have aimed to understand clinical…
View article: Can Digital Technology Advance the Development of Treatments for Alzheimer's Disease?
Can Digital Technology Advance the Development of Treatments for Alzheimer's Disease? Open
The report explores the potential digital technology has to generate novel endpoints and digital biomarkers for Alzheimer's disease drug development studies. Drawing from literature and novel pilots, we explore the value of innovative digi…
View article: Brain Monitoring Devices in Neuroscience Clinical Research: The Potential of Remote Monitoring Using Sensors, Wearables, and Mobile Devices
Brain Monitoring Devices in Neuroscience Clinical Research: The Potential of Remote Monitoring Using Sensors, Wearables, and Mobile Devices Open
The increasing miniaturization and affordability of sensors and circuitry has led to the current level of innovation in the area of wearable and microsensor solutions for health monitoring. This facilitates the development of solutions tha…